Drug intelligence / Profile preview

peiyuan tongnao

Development stage: Phase 4
Modality: Small Molecules
Administration: Oral

Overview

Peiyuan Tongnao (PYTN) is a traditional Chinese medicine capsule formulation widely used for the treatment of cerebrovascular diseases, particularly cerebral infarction and ischemic stroke. It is composed of multiple herbal ingredients and is believed to exert neuroprotective effects by improving blood circulation in the brain and supporting recovery after stroke. The precise mechanisms of action are not fully elucidated but are thought to involve anti-inflammatory effects, antioxidative stress responses, inhibition of neuronal apoptosis, and improvement in microcirculation within cerebral tissues[1][2][3][4]. Clinical use focuses on aiding recovery from ischemic events such as stroke with symptoms like hemiplegia or tongue deviation[5].

Brand names: Pei Yuan Tong NaoPeiyuan TongnaoPei-yuan-Tong-naoPYTN
Other names: Peiyuan Tongnao JiaonangPTC

Beyond the preview

Go deeper on peiyuan tongnao.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on peiyuan tongnao.